Treating Patients with Early Stage Lung Cancer
Corey J. Langer, MD, discusses the treatment of patients with early stage lung cancer.
Corey J. Langer, MD, professor of medicine, hematology/oncology division, University of Pennsylvania, Abramson Cancer Center, discusses the treatment of patients with early stage lung cancer.
Clinical Pearls
- The major concerns in early stage disease include proper surgical resection and clean proximal nodes
- In patients with N1 or N2 involvement or stage 1 patients with tumors larger than 4 centimeters, standard postoperative care is adjuvant platinum-based chemotherapy for 4 cycles
- Patients with early stage lung cancer should undergo reflex testing because the information on marker status can be used later if the patient relapses
Related Videos
Related Content
Phase 3 CheckMate -73L of Nivolumab/Ipilimumab in NSCLC Misses PFS End Point
May 13th 2024Article
Nivolumab with ipilimumab did not lead to progression-free survival benefits in patients with unresectable stage III non-small cell lung cancer, missing the primary end point of the CheckMate -73L study.
Read More
